Norges Bank Arvinas, Inc. Transaction History

Norges Bank

  • $736 Billion
  • Q4 2024

A detailed history of Norges Bank transactions in Arvinas, Inc. stock. As of the latest transaction made, Norges Bank holds 1,243,868 shares of ARVN stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,243,868
Holding current value
$10.1 Million
% of portfolio
0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$17.83 - $28.04 $22.2 Million - $34.9 Million
1,243,868 New
1,243,868 $23.8 Million
Q2 2024

Aug 14, 2024
BUY
$24.46 - $40.4 $26.4 Million - $43.6 Million
1,078,246 New
1,078,246 $28.7 Million
Q4 2023

Feb 09, 2024
BUY
$14.19 - $42.33 $12.5 Million - $37.2 Million
877,708 New
877,708 $36.1 Million
Q3 2023

Nov 13, 2024
BUY
$19.64 - $28.21 $9.93 Million - $14.3 Million
505,462 New
505,462 $9.93 Million
Q3 2023

Nov 13, 2023
SELL
$19.64 - $28.21 $14.4 Million - $20.7 Million
-733,355 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$21.73 - $31.43 $10.1 Million - $14.6 Million
-465,077 Reduced 43.13%
613,169 $15.2 Million
Q2 2023

Aug 14, 2023
SELL
$21.73 - $31.43 $15.2 Million - $22.1 Million
-701,755 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$26.15 - $37.26 $18.9 Million - $27 Million
724,569 New
724,569 $19.8 Million
Q4 2022

Feb 14, 2023
BUY
$32.47 - $57.24 $22.8 Million - $40.2 Million
701,755 New
701,755 $24 Million
Q3 2022

Nov 13, 2023
BUY
$41.87 - $57.99 $30.7 Million - $42.5 Million
733,355 New
733,355 $32.6 Million
Q2 2022

Aug 14, 2023
BUY
$36.01 - $74.24 $25.3 Million - $52.1 Million
701,755 New
701,755 $29.5 Million
Q1 2022

May 12, 2023
SELL
$60.27 - $81.57 $6.79 Million - $9.18 Million
-112,586 Reduced 16.04%
589,169 $39.7 Million
Q1 2022

May 09, 2022
SELL
$60.27 - $81.57 $37.1 Million - $50.2 Million
-615,370 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$65.85 - $96.21 $40.5 Million - $59.2 Million
615,370 New
615,370 $50.5 Million
Q3 2021

Nov 14, 2022
BUY
$73.2 - $107.87 $32 Million - $47.2 Million
437,305 New
437,305 $35.9 Million
Q3 2021

Nov 05, 2021
SELL
$73.2 - $107.87 $25.3 Million - $37.4 Million
-346,299 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$60.45 - $84.26 $20.9 Million - $29.2 Million
346,299 New
346,299 $26.7 Million
Q2 2021

Aug 10, 2021
SELL
$60.45 - $84.26 $21.5 Million - $30 Million
-355,685 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$58.19 - $91.37 $20.7 Million - $32.5 Million
355,685 New
355,685 $23.5 Million
Q1 2021

May 07, 2021
SELL
$58.19 - $91.37 $4.27 Million - $6.7 Million
-73,343 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$20.19 - $84.93 $1.48 Million - $6.23 Million
73,343 New
73,343 $6.23 Million
Q4 2020

Feb 10, 2021
SELL
$20.19 - $84.93 $1.8 Million - $7.57 Million
-89,077 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$22.99 - $36.34 $2.05 Million - $3.24 Million
89,077 New
89,077 $2.1 Million
Q3 2020

Nov 10, 2020
SELL
$22.99 - $36.34 $1.68 Million - $2.65 Million
-73,000 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$29.88 - $56.74 $2.18 Million - $4.14 Million
73,000 New
73,000 $2.45 Million
Q4 2018

Feb 08, 2019
SELL
$11.19 - $18.56 $111,900 - $185,600
-10,000 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$16.05 - $16.87 $160,500 - $168,700
10,000 New
10,000 $169,000

Others Institutions Holding ARVN

# of Institutions
223
Shares Held
70.9M
Call Options Held
1.52M
Put Options Held
346K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $433M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email